Download PDF
Z Gastroenterol 2011; 49(12): 1558-1560
DOI: 10.1055/s-0031-1281777
Kommentierte Referate

© Georg Thieme Verlag KG Stuttgart · New York

Mikrosatelliteninstabilität beim Kolonkarzinom: wichtig für die Entscheidung zur adjuvanten Therapie?

Microsatellite Instability in Colon Cancer: Important to Decide over Adjuvant Treatment?C. Treese, S. Daum
  • 1Charité, Universitätsmedizin Berlin
Further Information

Publication History





Publication Date:
02 December 2011 (online)

Also available at
    Permissions and Reprints

Sinicrope FA, Foster NR, Thibodeau SN, Marsoni S, Monges G, Labianca R, Yothers G, Allegra C, Moore MJ, Gallinger S, Sargent DJ. DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy. J Natl Cancer Inst 2011; 103: 863 – 875

1 FFCD = Federation Francophone de la Cancerologie Digestive; FU = fluorouracil; GIVIO = Gruppo Italiano Valutazione Interventi in Oncologia; NCCTG = North Central Cancer Treatment Group; NCIC = National Cancer Institute of Canada; NSABP = National Surgery Adjuvant Breast and Bowel Project; SD = standard deviation.

PD Dr. Severin Daum

Medizinische Klinik I, Gastroenterologie, Rheumatologie und Infektiologie, Charité, Universitätsmedizin Berlin

Campus Benjamin Franklin

12200 Berlin

Phone:  ++ 49/30/4 50 51 43 22

Fax:  ++ 49/30/4 50 51 49 90

Email: severin.daum@charite.de